| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C026114 |
2-xylene |
2-xylene results in increased expression of NFAT5 mRNA | increases expression | 20359517
|
| C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of NFAT5 mRNA | decreases expression | 18648102
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of NFAT5 mRNA | affects expression | 17562736
|
| D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of NFAT5 mRNA | increases expression | 18687144
|
| D001554 |
Benzene |
Benzene results in increased expression of NFAT5 mRNA | increases expression | 20359517
|
| C090535 |
benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal |
benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal inhibits the reaction [Doxorubicin results in increased degradation of NFAT5 protein] | decreases reaction|increases degradation | 17105721
|
| C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Doxorubicin results in increased degradation of NFAT5 protein] | decreases reaction|increases degradation | 17105721
|
| D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of NFAT5 mRNA | increases expression | 16934159
|
| D004317 |
Doxorubicin |
benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal inhibits the reaction [Doxorubicin results in increased degradation of NFAT5 protein] | decreases reaction|increases degradation | 17105721
|
| D004317 |
Doxorubicin |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Doxorubicin results in increased degradation of NFAT5 protein] | decreases reaction|increases degradation | 17105721
|
| D004317 |
Doxorubicin |
Doxorubicin affects the localization of NFAT5 protein | affects localization | 17105721
|
| D004317 |
Doxorubicin |
Doxorubicin results in decreased activity of NFAT5 protein | decreases activity | 17105721
|
| D004317 |
Doxorubicin |
Doxorubicin results in increased degradation of and results in decreased expression of NFAT5 protein | decreases expression|increases degradation | 17105721
|
| C004912 |
ethylbenzene |
ethylbenzene results in increased expression of NFAT5 mRNA | increases expression | 20359517
|
| D008752 |
Methylene Chloride |
Methylene Chloride results in increased expression of NFAT5 mRNA | increases expression | 20359517
|
| C030517 |
myxothiazol |
myxothiazol inhibits the reaction [Sodium Chloride results in increased activity of NFAT5 protein] | decreases reaction|increases activity | 16303854
|
| C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of NFAT5 mRNA | decreases expression | 17950772
|
| C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of NFAT5 mRNA] | decreases expression|increases reaction | 17950772
|
| D017382 |
Reactive Oxygen Species |
[Sodium Chloride results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFAT5 protein | increases abundance|increases activity | 16303854
|
| D012402 |
Rotenone |
Rotenone inhibits the reaction [Sodium Chloride results in increased activity of NFAT5 protein] | decreases reaction|increases activity | 16303854
|
| D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of NFAT5 mRNA | affects cotreatment|decreases expression | 19244175
|
| D012643 |
Selenium |
Selenium results in decreased expression of NFAT5 mRNA | decreases expression | 19244175
|
| D012965 |
Sodium Chloride |
myxothiazol inhibits the reaction [Sodium Chloride results in increased activity of NFAT5 protein] | decreases reaction|increases activity | 16303854
|
| D012965 |
Sodium Chloride |
Rotenone inhibits the reaction [Sodium Chloride results in increased activity of NFAT5 protein] | decreases reaction|increases activity | 16303854
|
| D012965 |
Sodium Chloride |
[Sodium Chloride results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFAT5 protein | increases abundance|increases activity | 16303854
|
| D012965 |
Sodium Chloride |
Sodium Chloride results in increased activity of NFAT5 protein | increases activity | 16303854
|
| C004648 |
testosterone enanthate |
testosterone enanthate results in increased expression of NFAT5 mRNA | increases expression | 17440010
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of NFAT5 mRNA | affects expression | 18691609
|
| D014050 |
Toluene |
Toluene results in increased expression of NFAT5 mRNA | increases expression | 20359517
|
| D014241 |
Trichloroethylene |
Trichloroethylene results in increased expression of NFAT5 mRNA | increases expression | 20359517
|
| D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of NFAT5 mRNA | affects cotreatment|decreases expression | 19244175
|
| D014810 |
Vitamin E |
Vitamin E results in decreased expression of NFAT5 mRNA | decreases expression | 19244175
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.72 | 11752688 14514962 15322242 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.99 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.54 | 17418594 |
| MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.68 | 3712494 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.46 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.46 | 16835633 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.42 | 21441931 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.83 | 11748828 |
| MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.27 | 11369114 17661222 14761424 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.71 | 10982225 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
| MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.89 | 1440618 11289319 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.37 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.37 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
2-xylene |
11.67 | 7457028 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
11.67 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.68 | 15746008 |
| MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
5.10 | 16183116 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.57 | 14601052 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.69 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzene |
2.35 | 11921183 17162533 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.35 | 16096432 15136595 18695136 16935488 15668708 16595493 16264153 15634643 15939500 16826403 19526202 17983394 18234424 15994142 18628466 11325840 15993339 15567936 16115903 18382427 17426702 17369602 15692762 16322301 |
| MESH:D001943 |
Breast Neoplasms |
|
Methylene Chloride |
2.35 | 15986119 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
2.35 | 15986119 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.80 | 16050911 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.68 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.69 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.45 | 7296757 3581430 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.45 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.45 | 16234567 18059187 17876044 16023760 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.35 | 7296757 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.35 | 16201981 1485588 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.60 | 6189445 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.30 | 18670907 16120746 18850075 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.44 | 17519947 17924179 17131338 16278810 15476868 15792986 16109756 17974986 15505089 16952015 17308081 17007740 16612575 16455267 16651473 15811867 16731534 17382496 17329180 16242529 16364871 17351982 16269455 18627295 17928571 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.90 | 17334414 16243910 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.51 | 10977129 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
2.67 | 7505956 |
| MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.72 | 9294310 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.52 | 19486331 9022650 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.52 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.05 | 16354765 15340226 12621046 8697196 15668235 |
| MESH:D003092 |
Colitis |
|
Selenium |
3.65 | 17936198 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
7.22 | 15643154 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Reactive Oxygen Species |
7.22 | 15736158 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
7.22 | 10048152 15322242 20055451 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
7.22 | 9294310 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
7.22 | 19769572 |
| MESH:D003643 |
Death |
|
Toluene |
5.54 | 6431079 |
| MESH:D003872 |
Dermatitis |
|
Benzene |
4.64 | 15902427 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.68 | 12868966 18759878 8156756 2524372 14531868 11906362 11298694 8970840 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.37 | 18249437 |
| MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.37 | 3621924 2952479 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
18.10 | 9653073 18692083 7440962 1440618 9022650 18289764 6482804 18648102 9328219 8291058 11289319 6679447 16192314 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
18.10 | 19370779 15968718 11739529 19085960 18071297 15619225 10774834 19923254 12594235 10915739 16485898 16081117 19164858 11461765 10663392 19416960 16393943 16109766 12153990 16227642 17906064 11421492 12540782 12958197 12392966 14725611 19420014 11834606 12705907 16781746 17562736 17522070 14550746 14986274 11529661 2444490 11743745 19739265 18713872 16177239 11287661 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
18.10 | 17851650 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
18.10 | 17416283 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
18.10 | 15131321 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
18.10 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
18.10 | 7120509 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.97 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.79 | 18602426 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.79 | 11462148 |
| MESH:C538011 |
Eales disease |
|
Vitamin E |
4.57 | 9068938 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
6.14 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.14 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.77 | 15322242 18230668 16714409 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.37 | 17359293 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.91 | 9294722 10568697 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.03 | 18037988 |
| MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.08 | 3581430 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.65 | 20131406 19236843 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
| MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.89 | 6705139 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.46 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.82 | 20067830 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.55 | 16983495 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.26 | 17150277 |
| MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.91 | 7505956 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.44 | 15692506 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.34 | 11294989 10048152 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.34 | 16080930 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.39 | 16707910 16144979 18674790 16495754 14766674 12587719 18006777 16244371 17875725 16330681 16879835 17888722 16244372 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
11.34 | 17481944 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
11.34 | 20558911 |
| MESH:D006333 |
Heart Failure |
|
Selenium |
11.34 | 17162251 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.78 | 15692506 |
| MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.53 | 16183116 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
| MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.39 | 6705139 |
| MESH:D006529 |
Hepatomegaly |
|
2-xylene |
13.83 | 7457013 7457028 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.83 | 19772884 18467677 16221962 19176532 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.83 | 15340226 12621046 16120746 |
| MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.66 | 16490937 16863852 |
| MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.62 | 17440010 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.30 | 17606976 18501091 15147373 |
| MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.84 | 14716179 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.92 | 16354765 8697196 16959395 15340226 18606429 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.60 | 16870215 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.07 | 20558911 |
| MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.81 | 15034207 |
| MESH:D006973 |
Hypertension |
|
Benzene |
8.59 | 17940673 |
| MESH:D006973 |
Hypertension |
|
Sodium Chloride |
8.59 | 11507004 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.59 | 18850075 18670907 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.79 | 12878042 12200463 |
| MESH:D007251 |
Influenza, Human |
|
Selenium |
10.53 | 16624496 |
| MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.53 | 16624496 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.55 | 16306350 |
| MESH:D002532 |
Intracranial Aneurysm |
|
Reactive Oxygen Species |
4.83 | 19381132 |
| MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.89 | 9022650 8074119 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 16580747 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.67 | 15629191 12587719 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.67 | 15699352 15369732 16775033 |
| MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
9.67 | 12488133 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.58 | 16707910 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
9.58 | 16518626 |
| MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.86 | 6582329 |
| MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Sodium Chloride |
4.82 | 9499605 |
| MESH:D007938 |
Leukemia |
|
Benzene |
3.33 | 17119257 14694614 15935818 18335105 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.03 | 16085563 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.20 | 17506065 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.68 | 19478238 |
| MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.11 | 9327722 15034207 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.81 | 16439617 16595196 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.81 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.81 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
4.81 | 16169303 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.60 | 19014921 11587558 16611625 19784758 12969438 16610002 19460945 12587719 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.12 | 17185352 16871587 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.08 | 16377806 20007298 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.08 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
17.81 | 598648 1399818 3712494 6587162 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
17.81 | 12562636 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
17.81 | 16842330 17085340 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.81 | 12151625 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
17.81 | 7955063 |
| MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.09 | 16863852 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.68 | 14698565 |
| MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.89 | 17365036 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzene |
6.46 | 12562636 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.46 | 6189445 17418594 |
| MESH:D008175 |
Lung Neoplasms |
|
Methylene Chloride |
6.46 | 15172992 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.46 | 11884234 19555203 |
| MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
6.46 | 11062179 |
| MESH:D008223 |
Lymphoma |
|
Benzene |
7.53 | 17119257 17584886 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.53 | 16098063 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.68 | 17654614 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.44 | 15621674 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
4.31 | 12562636 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
9.63 | 11921183 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
9.63 | 15458769 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
9.63 | 15318939 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.81 | 16827129 |
| MESH:D008545 |
Melanoma |
|
Reactive Oxygen Species |
3.81 | 17992120 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.44 | 19513568 |
| MESH:D008607 |
Mental Retardation |
|
Toluene |
3.61 | 9294310 |
| MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
9.96 | 16966607 18303189 16166281 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
9.96 | 17638057 |
| MESH:D008654 |
Mesothelioma |
|
Selenium |
9.96 | 15107826 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.38 | 15792986 |
| MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
5.11 | 9294310 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.66 | 17415656 |
| MESH:D009101 |
Multiple Myeloma |
|
Benzene |
3.57 | 17119195 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.38 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.53 | 15857846 19429709 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.53 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.91 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.84 | 16411023 |
| MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.67 | 3581430 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.67 | 18259882 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.12 | 17405874 |
| MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
5.12 | 11911487 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.64 | 16636307 16899518 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.89 | 16889571 15640375 |
| MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.78 | 17356569 18619942 15790535 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.09 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.17 | 6679447 |
| MESH:D009436 |
Neural Tube Defects |
|
Benzene |
7.17 | 15643154 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.20 | 15555623 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.76 | 18514411 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.78 | 20558911 |
| MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.77 | 6482804 4026338 |
| MESH:D009784 |
Occupational Diseases |
|
Benzene |
8.77 | 17119257 16737584 15612468 15913788 15727169 17178637 15935809 15576619 17479406 |
| MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.89 | 3988306 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.01 | 15930896 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
2.93 | 12562636 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.29 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Reactive Oxygen Species |
3.65 | 15580305 |
| MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.35 | 7296757 |
| MESH:D010300 |
Parkinson Disease |
|
Rotenone |
2.93 | 11535288 16140633 11445065 16412576 19114014 18191903 15451049 18619942 19232380 |
| MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.96 | 15927086 15574749 15795934 18197244 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
| MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.34 | 6228378 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.03 | 17983394 |
| MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.76 | 15087411 |
| MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.76 | 10923243 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.03 | 17638057 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.06 | 11896295 11399792 11118676 11222880 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.45 | 15897917 15749863 16729912 16888761 16868541 18437689 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.45 | 15084515 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.98 | 17322281 17975199 15814490 17365031 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.09 | 17922066 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.32 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
| MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.28 | 3692021 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.87 | 17203757 15625365 17710206 16767912 18313854 15675481 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.11 | 16326096 14601052 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.66 | 17846226 |
| MESH:D012640 |
Seizures |
|
Toluene |
3.63 | 6431079 9294310 |
| MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.41 | 18709164 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.48 | 15692506 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.48 | 16192470 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.44 | 15625365 17203757 16767912 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
3.21 | 12562636 |
| MESH:D013274 |
Stomach Neoplasms |
|
Sodium Chloride |
3.21 | 16646055 |
| MESH:D020521 |
Stroke |
|
Vitamin E |
3.41 | 16517955 |
| MESH:D013733 |
Testicular Diseases |
|
Toluene |
4.83 | 10048760 10514026 |
| MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.82 | 10850423 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.77 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.93 | 6587162 6582329 3712494 1399818 7505956 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
6.93 | 16010429 17909728 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.01 | 8074119 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.01 | 17653716 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.85 | 10982225 |
| MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
4.20 | 12562636 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.09 | 17334414 17638931 17678736 16364871 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |